Naoto Yamamoto
Papers
1
Total Citations
9
H-Index
1
About
Dr. Naoto Yamamoto is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for pancreatic cancer treatment, with a particular focus on distal pancreatectomy. His most impactful contribution is serving as principal investigator for the landmark JCOG2202 (LAPAN) study, a multi-institutional randomized phase III trial comparing minimally invasive distal pancreatectomy (MIDP) against open surgery for pancreatic cancer. This pivotal work, published in 2024, addresses the critical gap in evidence regarding the oncologic safety of laparoscopic and robotic approaches, which have gained widespread adoption despite insufficient long-term outcome data. The study has already garnered 9 citations shortly after publication, reflecting its immediate influence on surgical practice. Dr. Yamamoto’s research directly tackles the central question of whether MIDP can match open surgery in achieving complete tumor resection while offering improved recovery. His work is instrumental in shaping evidence-based guidelines for pancreatic cancer surgery, balancing the benefits of minimally invasive techniques with rigorous oncologic standards. Through this high-impact trial, Dr. Yamamoto is helping define the future standard of care for patients with pancreatic cancer.
Research Focus
Key Achievements
Top Papers
- 1